Maria Jose Herrero
Overview
Explore the profile of Maria Jose Herrero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Comes-Raga A, Sendra L, Marcaida-Benito G, Alino S, Herrero M
Adv Lab Med
. 2024 Dec;
5(4):432-438.
PMID: 39713527
No abstract available.
2.
Diz-de Almeida S, Cruz R, Luchessi A, Lorenzo-Salazar J, de Heredia M, Quintela I, et al.
Elife
. 2024 Oct;
13.
PMID: 39361370
The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited...
3.
Safe Procedure for Efficient Hydrodynamic Gene Transfer to Isolated Porcine Liver in Transplantation
Sendra L, Navasquillo M, Montalva E, Calatayud D, Perez-Rojas J, Maupoey J, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338774
Although calcineurin inhibitors are very effective as immunosuppressants in organ transplantation, complete graft acceptance remains as a challenge. Transfer of genes with immunosuppressant functions could contribute to improving the clinical...
4.
Agullo L, Muriel J, Margarit C, Escorial M, Garcia D, Herrero M, et al.
J Clin Med
. 2023 May;
12(10).
PMID: 37240556
Analgesic-response variability in chronic noncancer pain (CNCP) has been reported due to several biological and environmental factors. This study was undertaken to explore sex differences linked to and DNA methylation...
5.
Urtasun A, Olivera G, Sendra L, Alino S, Berlanga P, Gargallo P, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900216
Background: Pharmacogenetics is a personalized medicine tool that aims to optimize treatments by adapting them to each individual's genetics, maximizing their efficacy while minimizing their toxicity. Infants with cancer are...
6.
Cruz R, Diz-de Almeida S, de Heredia M, Quintela I, Ceballos F, Pita G, et al.
Hum Mol Genet
. 2022 Jun;
31(22):3789-3806.
PMID: 35708486
Here, we describe the results of a genome-wide study conducted in 11 939 coronavirus disease 2019 (COVID-19) positive cases with an extensive clinical information that were recruited from 34 hospitals...
7.
Fernandez-Delgado M, Sendra L, Herrero M, Olivera-Pasquini G, Batista-Duharte A, Alino S
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628649
Therapeutic oligonucleotides have achieved great clinical interest since their approval as drug agents by regulatory agencies but their access and distribution in blood cells are not completely known. We evaluated...
8.
Olivera G, Sendra L, Herrero M, Berlanga P, Gargallo P, Yanez Y, et al.
Cancer Drug Resist
. 2022 May;
2(1):53-68.
PMID: 35582138
The aim of this work was to supply an overview of the germline Pharmacogenetics that can be already implemented in the oncology clinical practice. An explanation of the three pillars...
9.
Pinto-Merino A, Labrador J, Zubiaur P, Alcaraz R, Herrero M, Montesinos P, et al.
Pharmaceutics
. 2022 Mar;
14(3).
PMID: 35335935
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by remarkable toxicity and great variability in response to treatment. Plenteous pharmacogenetic studies have already been published for classical therapies, such...
10.
Sendra L, Olivera G, Lopez-Andujar R, Serrano C, Rojas L, Montalva E, et al.
Pharmaceutics
. 2022 Feb;
14(2).
PMID: 35214086
Some gene polymorphisms have been previously associated individually with tacrolimus efficacy and toxicity, but no long-term study to determine the role of pharmacogene variants in the clinical evolution of liver-transplanted...